LCT In The News

1 June 2022

Australian Pork - "Artificial intelligence and pig brain tissue combat Parkinson's"

31 May 2022

Market Herald - "Living Cell Technologies (ASX:LCT) raises $1.28m for NTCELL"

Biotech company Living Cell Technologies (LCT) has raised $1.285 million through a private placement to boost its research into Parkinson’s Disease, reports The Market Herald.

23 May 2022

Kalkine Media - "Major Breakthrough! Living Cell Technologies (ASX:LCT) to use AI in research for Parkinson’s"

LCT is set to apply AI in NTCELL research to augment the quality of its third clinical trial in Parkinson’s disease, reports Kalkine Media.

31 March 2022

Biotech Dispatch - "NTCELL to be produced in Australia under UTS research agreement"

NTCELL will be produced in Australia under a research agreement with the University of Technology Sydney and the Australian Foundation for Diabetes Research, reports Biotech Dispatch.

1 February 2022

NZ pigs possible key to treating Parkinson's

25 January 2022

"Why pigs on this remote Auckland island may be the key to treating Parkinson’s disease" - The Sentiment

"Of all the places in the world where you thought a cure for Parkinson’s disease might be found, the remote sub-Antarctic Auckland Islands might not have been your first choice but that’s exactly where biotech company Living Cell Technologies (ASX: LCT) will obtain tissue for their clinical trials," reports The Sentiment.